4/A

PRIMARY DOCUMENT

Company: ENDONOVO THERAPEUTICS, INC.
Filed: January 14, 2019
Period of Report: June 15, 2015
Accession Number: 0001645470-19-000002

View Document ↗ View on SEC.gov ↗